EyeBrain Raises Second Funding Round from Three New Investors

EyeBrain, a start-up developing brain function markers for neurological and psychiatric diseases, has raised 3.3 million euros ($4.3 million) in a second funding round. The additional capital was provided by three new investors, Octalfa, Sudinnova and CM-CIC Capital Innovation, which join EyeBrain’s existing shareholders, CapDecisif Management and G1JIDF.

North AmericaUSBriefs